CITGO SUPERGARD Air Cooled

Hazard statements (CLP)

H221

Code

Statements

H221

Flammable gas

SECTION 2: Hazards identification

Also see Emergency Overview and Hazard Ratings on the top of Page 1 of this MSDS. Major Route(s) of Entry Skin contact. Eye contact. Inhalation. Signs and Symptoms of Acute Exposure Inhalation At elevated temperatures or in enclosed spaces, product mist or vapors may irritate the mucous membranes of the nose, the throat, bronchi, and lungs. Eye Contact This product can cause transient mild eye irritation with short-term contact with liquid sprays or mists. Symptoms include stinging, watering, redness, and swelling. Skin Contact This product can cause mild, transient skin irritation. The severity of irritation will depend on the amount of material that is applied to the skin and the speed and thoroughness that it is removed. Symptoms include redness, itching, and burning of the skin. Repeated or prolonged skin contact can produce moderate irritation (dermatitis). Ingestion If swallowed, large volumes of material can cause generalized depression, headache, drowsiness, nausea, vomiting and diarrhea. Smaller doses can cause a laxative effect. If aspirated into the lungs, liquid can cause lung damage.

Potential chronic health

Prolonged and/or repeated skin contact may cause irritation and inflamation. Symptoms Summary include defatting, redness, dryness, blistering eczema-like lesions, scaly dermatitis, and/or more serious skin disorders. Chronic effects of ingestion and subsequent aspiration into the lungs may cause pneumatocele (lung cavity) formation and chronic lung dysfunction. Conditions Aggravated Disorders of the following organs or organ systems that may be aggravated by significant by Exposure exposure to this material or its components include: Skin, Respiratory System, Liver, Kidneys, Central Nervous System (CNS) Target Organs May cause damage to the following organs: upper respiratory tract, skin, eyes. Carcinogenic Potential This product is not known to contain any components at concentrations above 0.1% which